vs
Side-by-side financial comparison of Dexcom (DXCM) and Williams-Sonoma, Inc. (WSM). Click either name above to swap in a different company.
Williams-Sonoma, Inc. is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× Dexcom). Dexcom runs the higher net margin — 21.2% vs 12.8%, a 8.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 4.6%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -9.1%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Williams Sonoma is an American retailer of cookware, appliances, and home furnishings. It is owned by Williams-Sonoma, Inc., and was founded by Charles E. (Chuck) Williams in 1956.
DXCM vs WSM — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.9B |
| Net Profit | $267.3M | $241.6M |
| Gross Margin | 62.9% | 46.1% |
| Operating Margin | 25.6% | 17.0% |
| Net Margin | 21.2% | 12.8% |
| Revenue YoY | 21.6% | 4.6% |
| Net Profit YoY | 153.6% | -3.0% |
| EPS (diluted) | $0.67 | $1.96 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.9B | ||
| Q3 25 | $1.2B | $1.8B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.0B | $2.5B | ||
| Q4 24 | $1.1B | $1.8B | ||
| Q3 24 | $994.2M | $1.8B | ||
| Q2 24 | $1.0B | $1.7B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $241.6M | ||
| Q3 25 | $283.8M | $247.6M | ||
| Q2 25 | $179.8M | $231.3M | ||
| Q1 25 | $105.4M | $384.9M | ||
| Q4 24 | $151.7M | $249.0M | ||
| Q3 24 | $134.6M | $225.7M | ||
| Q2 24 | $143.5M | $265.7M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 46.1% | ||
| Q3 25 | 60.5% | 47.1% | ||
| Q2 25 | 59.5% | 44.3% | ||
| Q1 25 | 56.9% | 45.2% | ||
| Q4 24 | 58.9% | 46.7% | ||
| Q3 24 | 59.7% | 46.2% | ||
| Q2 24 | 62.4% | 48.3% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 17.0% | ||
| Q3 25 | 20.1% | 17.9% | ||
| Q2 25 | 18.4% | 16.8% | ||
| Q1 25 | 12.9% | 20.1% | ||
| Q4 24 | 17.0% | 17.8% | ||
| Q3 24 | 15.3% | 16.2% | ||
| Q2 24 | 15.7% | 19.5% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 12.8% | ||
| Q3 25 | 23.5% | 13.5% | ||
| Q2 25 | 15.5% | 13.4% | ||
| Q1 25 | 10.2% | 15.6% | ||
| Q4 24 | 13.6% | 13.8% | ||
| Q3 24 | 13.5% | 12.6% | ||
| Q2 24 | 14.3% | 16.0% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $1.96 | ||
| Q3 25 | $0.70 | $2.00 | ||
| Q2 25 | $0.45 | $1.85 | ||
| Q1 25 | $0.27 | $1.02 | ||
| Q4 24 | $0.37 | $1.96 | ||
| Q3 24 | $0.34 | $1.74 | ||
| Q2 24 | $0.35 | $4.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $884.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.1B |
| Total Assets | $6.3B | $5.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $884.7M | ||
| Q3 25 | $1.8B | $985.8M | ||
| Q2 25 | $1.2B | $1.0B | ||
| Q1 25 | $904.9M | $1.2B | ||
| Q4 24 | $606.1M | $826.8M | ||
| Q3 24 | $621.2M | $1.3B | ||
| Q2 24 | $939.2M | $1.3B |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.1B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.6B | $2.2B | ||
| Q1 25 | $2.3B | $2.1B | ||
| Q4 24 | $2.1B | $1.9B | ||
| Q3 24 | $2.0B | $2.3B | ||
| Q2 24 | $2.4B | $2.2B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $5.3B | ||
| Q3 25 | $7.5B | $5.2B | ||
| Q2 25 | $7.3B | $5.2B | ||
| Q1 25 | $6.8B | $5.3B | ||
| Q4 24 | $6.5B | $5.0B | ||
| Q3 24 | $6.4B | $5.2B | ||
| Q2 24 | $6.8B | $5.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $316.3M |
| Free Cash FlowOCF − Capex | — | $248.1M |
| FCF MarginFCF / Revenue | — | 13.2% |
| Capex IntensityCapex / Revenue | — | 3.6% |
| Cash ConversionOCF / Net Profit | — | 1.31× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $316.3M | ||
| Q3 25 | $659.9M | $282.7M | ||
| Q2 25 | $303.0M | $118.9M | ||
| Q1 25 | $183.8M | $633.5M | ||
| Q4 24 | $301.4M | $253.5M | ||
| Q3 24 | $199.5M | $246.5M | ||
| Q2 24 | $279.4M | $226.8M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $248.1M | ||
| Q3 25 | $579.4M | $230.7M | ||
| Q2 25 | $208.9M | $60.7M | ||
| Q1 25 | $96.8M | $566.3M | ||
| Q4 24 | $176.8M | $170.1M | ||
| Q3 24 | $88.3M | $215.1M | ||
| Q2 24 | $213.3M | $187.3M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 13.2% | ||
| Q3 25 | 47.9% | 12.6% | ||
| Q2 25 | 18.1% | 3.5% | ||
| Q1 25 | 9.3% | 23.0% | ||
| Q4 24 | 15.9% | 9.4% | ||
| Q3 24 | 8.9% | 12.0% | ||
| Q2 24 | 21.2% | 11.3% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 3.6% | ||
| Q3 25 | 6.7% | 2.8% | ||
| Q2 25 | 8.1% | 3.4% | ||
| Q1 25 | 8.4% | 2.7% | ||
| Q4 24 | 11.2% | 4.6% | ||
| Q3 24 | 11.2% | 1.8% | ||
| Q2 24 | 6.6% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.31× | ||
| Q3 25 | 2.33× | 1.14× | ||
| Q2 25 | 1.69× | 0.51× | ||
| Q1 25 | 1.74× | 1.65× | ||
| Q4 24 | 1.99× | 1.02× | ||
| Q3 24 | 1.48× | 1.09× | ||
| Q2 24 | 1.95× | 0.85× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
